Research Article
Postintravitreal Injection Endophthalmitis: Incidence, Characteristics, Management, and Outcome
Table 3
Best corrected visual acuity (logMAR) in post-IVI endophthalmitis along the study period.
| | BCVA (logMAR) | BCVA (Snellen) |
| Baseline, median (IQR) | 0.30 (0.18–0.70) | ≈6/12 | At presentation, median (IQR) | 1.78 (0.82–2.10) | ≈6/120-CF | Change from the baseline | +1.26 ([+0.40]–[+1.68]) | | At 6 m follow-up, median (IQR) | 0.61 (0.30–1.07) | ≈6/24 | Change from the baseline | +0.19 ([0.00]–[+0.44]) | | Change from presentation | −0.88 ([−1.30]–[−0.20]) | | At 12 m follow-up, median (IQR) | 0.74 (0.27–1.32) | ≈6/24 | Change from the baseline | +0.19 ([0.00]–[+0.62]) | | Change from presentation | −0.92 ([−1.18]–[−0.05]) | |
|
|
IQR: interquartile range; IVI: intravitreal injection; logMAR: logarithm of the minimum angle of resolution.
|